With an aim to progress the understanding of the role of these cells in the ongoing anti-tumor immune reactions occurring in lymph nodes of breast cancer patients, we here investigated the CD169+ macrophage- and B-cell compartments using spatial proteomics analysis in paired UnLN and LNM lymph nodes from five breast cancer patients. The gene discussed is SIGLEC1; the disease is breast cancer.